Pfizer’s Innovative Drug Pipeline Provides Ample Reason To Buy It Here (NYSE:PFE)
J Studios Investment Thesis I think it is safe to say that Pfizer Inc. (NYSE:PFE) is probably one of the least wanted stocks, not only in the pharmaceutical complex of stocks but in the broader view of the market. Pfizer has been plagued by a myriad of issues that are posing severe headwinds for the…